Inflammatory signaling in the CNS is crucial in the development of obesityassociated insulin and leptin resistance. Tsaousidou et al. demonstrate that constitutive JNK activation in agouti-related peptide (AgRP)-expressing neurons is sufficient to induce weight gain and leptin resistance in mice, whereas IKK2 activation fails to cause obesity but blunts insulin signaling and impairs systemic glucose homeostasis. The data reveal distinct effects of c-Jun N-terminal kinase (JNK)-and inhibitor of nuclear factor kappa-B kinase (IKK)-dependent signaling in AgRP neurons, which cooperate in the manifestation of the metabolic syndrome.
In Brief
Inflammatory signaling in the CNS is crucial in the development of obesityassociated insulin and leptin resistance.
Tsaousidou et al. demonstrate that constitutive JNK activation in agouti-related peptide (AgRP)-expressing neurons is sufficient to induce weight gain and leptin resistance in mice, whereas IKK2 activation fails to cause obesity but blunts insulin signaling and impairs systemic glucose homeostasis. The data reveal distinct effects of c-Jun N-terminal kinase (JNK)-and inhibitor of nuclear factor kappa-B kinase (IKK)-dependent signaling in AgRP neurons, which cooperate in the manifestation of the metabolic syndrome.
INTRODUCTION
Inflammatory processes play a crucial role during the development of obesity and diabetes mellitus (Hotamisligil, 2008) . In adipose tissue, obesity leads to the recruitment of immune cells, which release cytokines such as tumor necrosis factor and interleukin-6 (Hotamisligil, 2008) . These and other cytokines are able to activate inflammatory signaling cascades such as c-Jun N-terminal kinase 1 (JNK1) and inhibitor of nuclear factor kappa-B kinase 2 (IKK2) (Li and Verma, 2002; Bogoyevitch, 2006) in insulin target tissues, thereby promoting the development of insulin resistance. The critical role of these kinases in obesity-induced insulin resistance has been defined through the generation of haploinsufficient conditional IKK2 knockout mice as well as hepatocyte-and myeloid-cell-specific IKK2-deficient mice, which are protected against systemic insulin resistance and glucose intolerance (Yuan et al., 2001; Arkan et al., 2005; Cai et al., 2005) . Similarly, conventional JNK1, but not JNK2, knockout mice are protected against obesity and glucose intolerance (Hirosumi et al., 2002) . In addition to obesity-associated activation of cytokine signaling, obesity can overload the cellular protein-folding capacity, leading to activation of the ER stress response, which in turn activates JNK1 and IKK2 (Ozcan et al., 2004 (Ozcan et al., , 2006 . Moreover, nutrient components such as saturated fatty acids can activate both JNK1 and IKK2 signaling through the engagement of Toll-like receptor (TLR)-dependent signaling or as a consequence of excessive ceramide synthesis (Shi et al., 2006; Holland et al., 2007) . Taken together, activation of these two kinases represents a hallmark in the development of insulin resistance in peripheral tissues.
In the CNS, the onset of hypothalamic leptin and insulin resistance is a key event in the development of obesity and impaired glucose homeostasis (Vogt and Brü ning, 2013; Plum et al., 2006a; . Both the adipose-tissue-derived hormone leptin and the pancreatic hormone insulin act on hypothalamic neurons to decrease food intake and hepatic glucose production and, further, to increase energy expenditure (Obici et al., 2002a, b; Ring and Zeltser, 2010) . Several hypothalamic neurons are directly regulated by these hormones, with the role of pro-opiomelanocortin (POMC) and the agouti-related peptide (AgRP) neurons being best defined. Acute ablation of POMC neurons induces hyperphagia, whereas ablation of AgRP neurons leads to anorexia (Gropp et al., 2005; Luquet et al., 2005) . Similarly, optogenetic activation of POMC neurons reduces food intake and body weight, whereas activation of AgRP evokes voracious feeding (Aponte et al., 2011) . Accordingly, leptin and insulin receptor signaling in POMC or AgRP neurons is necessary for normal regulation of body weight and glucose homeostasis (Balthasar et al., 2004; Kitamura et al., 2006; van de Wall et al., 2008; Belgardt et al., 2008; Xu et al., 2007) . Importantly, lack of insulin signaling in AgRP neurons is sufficient to deregulate hepatic glucose production (Kö nner et al., 2007; Lin et al., 2010) , whereas combined leptin and insulin receptor deficiency in POMC neurons induces systemic insulin resistance (Hill et al., 2010) . Of note, both POMC and AgRP neurons are intimately involved in the normal regulation of energy homeostasis not only in rodents but also in humans (Coll et al., 2007) .
Whereas these and other investigations have defined neuronal populations directly targeted by insulin and leptin for the regulation of energy homeostasis and glucose metabolism, multiple studies have revealed the development of insulin and leptin resistance in the CNS of obese animals and human patients (Mü nzberg et al., 2004; Enriori et al., 2007; Hallschmid et al., 2008; .
Both ER stress and increased proinflammatory cytokine expression have been detected in the hypothalami of obese mice and rats (De Souza et al., 2005; Ozcan et al., 2009 ). Likewise, neuronal ablation of the TLR adaptor molecule MyD88 is sufficient to maintain hypothalamic leptin sensitivity despite acute palmitate treatment or in chronically obese mice (Kleinridders et al., 2009) , and hypothalamic IKK2 and JNK1 activation has been reported in obese mice and rats (De Souza et al., 2005; Zhang et al., 2008; . Conversely, mice with CNS-wide ablation of IKK2 were protected from high-fat diet (HFD)-induced obesity and glucose intolerance (Zhang et al., 2008) , and we and others could demonstrate that JNK1 ablation in the CNS is sufficient to improve hypothalamic and systemic insulin sensitivity upon HFD consumption Sabio et al., 2010; Unger et al., 2010) .
However, whereas both neuronal JNK1 and IKK2 inhibition protects from HFD-associated pathologies, it has not yet been demonstrated in which hypothalamic neuronal population JNK1 and/or IKK2 action deregulates energy and/or glucose homeostasis and whether neuron-restricted JNK1 and/or IKK2 activation are sufficient to alter energy and glucose homeostasis. In the present study, we demonstrate that activation of JNK signaling specifically in AgRP neurons results in increased body weight and adiposity by progressively impairing neuronal leptin signaling and systemic leptin sensitivity. On the other hand, IKK2 activation promotes insulin resistance in AgRP neurons and ultimately also in the periphery without affecting energy homeostasis. Thus, we reveal that activation of both IKK and JNK signaling in AgRP neurons is sufficient to promote the development of hallmarks of the metabolic syndrome, but we also identify distinct and nonoverlapping roles for both inflammatory signaling mediators in AgRP neurons in this process. ). Immunostaining for phosphorylated c-Jun-as a readout for JNK activation and a crucial regulator of hypothalamic inflammation (De Souza et al., 2005; Sabio et al., 2010; Unger et al., 2010 )-in combination with GFP revealed an $3-fold increase of p-c-Jun immunoreactivity in GFP-positive neurons in NPY GFP mice after HFD consumption compared to the NCD-fed NPY GFP mice (Figures 1A and 1B) .
RESULTS

Activation of JNK Signaling in AgRP Neurons
These data indicate that, indeed early during the course of HFD feeding, JNK is activated in AgRP neurons.
To address whether JNK activation per se in AgRP neurons, as observed upon obesity development and HFD consumption (Figures 1A and 1B) , is sufficient to induce metabolic abnormalities, we sought to generate a genetic mouse model for cell-type-specific JNK activation. Constitutive activation of JNK has previously been achieved by expression of a constitutively active version of the upstream kinase JNKK2/MKK7 (MKK7D; Wang et al., 1998) or a fusion protein consisting of JNKK2/MKK7 and JNK1 (JNKK2-JNK1; Zheng et al., 1999) . Thus, we generated mice allowing for the conditional expression of a MKK7D-JNK1 fusion protein upon Cre-recombinase-induced excision of a transcriptional Stop cassette (R26Stop FL JNK1CA mice) from the ROSA26 locus (Pal et al., 2013) . In order to activate JNK signaling in AgRP neurons, we crossed R26Stop FL JNK1CA mice with mice expressing the Cre-recombinase in these cells (AgRPCre +/À ; Tong et al., 2008) . To investigate the efficiency of this transgenic approach to activate JNK, we generated reporter mice expressing GFP in AgRP neurons by crossing the AgRP Cre with the Z/EG mice, in the presence or absence of JNK1CA expression. Immunostaining for phosphorylated c-Jun -as a read-out for JNK activation-in combination with GFP revealed that less than 20% of GFP + -AgRP neurons exhibited p-c-Jun immunoreactivity in lean control animals, whereas in AgRP JNK1CA;GFP mice, more than 70% of GFP + -AgRP neurons showed detectable phosphorylation of c-Jun ( Figures 1C and 1D ), in fact, to similar degree as observed upon HFD feeding. Importantly, constitutive JNK activation in AgRP neurons did not affect the total number of GFP + -AgRP cells, although JNK1 had been implicated in a celltype-specific regulation of cell death and survival (Bogoyevitch, 2006;  Figure 1E ; Figures 1F-1H ). We did not observe any differences in other basic electrophysiological properties, such as input resistance, cell capacitance, and spike-frequency adaptation ( Figure S1 ).
JNK Activation in AgRP Neurons Causes Cellular and Systemic Leptin Resistance
Apart from regulating neuronal firing of AgRP neurons, leptin exerts its regulatory role on feeding behavior through Stat3-dependent regulation of neuropeptide expression, including that of AgRP and NPY (Bates and Myers, 2003) . Thus, we directly assessed leptin's ability to activate STAT3 phosphorylation in AgRP neurons of AgRP JNK1CA and control mice. To this end, we employed mice, which allow for Cre-dependent expression of b-galactosidase (Plum et al., 2006b) , and crossed these animals with AgRP JNK1CA mice, yielding both control mice with LacZ-positive cells ( Figure S2A ; for detailed information please see Supplemental Experimental Procedures). Thus, activating JNK signaling in AgRP neurons induces leptin resistance in these cells. This effect is AgRP-cell-specific, because pSTAT3 immunoreactivity after leptin stimulation is not affected in non-AgRP cells (Figures 2C and S2B) . To investigate systemic leptin sensitivity, control and AgRP JNK1CA mice were injected twice daily for 3 consecutive days with saline followed by twice-daily injections for 3 consecutive days with 2 mg/kg leptin. Leptin treatment significantly reduced food intake and body weight in both control and AgRP JNK1CA mice at 8 weeks of age ( Figures 2D and 2E ). Importantly, at the age of 15 weeks, leptin treatment failed to suppress food intake and to reduce body weight in AgRP JNK1CA mice, whereas control mice still responded to the food-intake-and body-weight-reducing action of leptin (Figures 2F and 2G) . Of note, leptin resistance at this age occurred in weight-matched animals to rule out a potential confounding effect of increased (n = 7) mice at 8 weeks of age. Data represent percentage of basal body weight (the body weight in the beginning of each treatment) after a 3-day (72 hr) treatment with twice-daily injections (12 hr apart) of saline followed by a 3-day treatment with twicedaily injections of 2 mg/kg leptin.
(E) Changes in food intake after intraperitoneal leptin treatment in control (n = 7) and AgRP
JNK1CA
(n = 7) mice at 8 weeks of age. Data represent daily food intake after a 3-day (72 hr) treatment with twice-daily injections (12 hr apart) of saline followed by a 3-day treatment with twice-daily injections of 2 mg/kg leptin. (F) As in (D), but at 15 weeks of age of control (n = 10) and AgRP JNK1CA (n = 4) mice.
(G) As in (E), but at 15 weeks of age of control (n = 10) and AgRP JNK1CA (n = 4) mice.
Displayed values are means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S2 .
body weight between the two genotypes ( Figures S2D and S2E ). Collectively, these experiments reveal that chronic activation of JNK signaling in AgRP neurons is sufficient to initially cause cell-autonomous and subsequently systemic leptin resistance.
Activation of JNK Signaling in AgRP Neurons Causes Obesity
To address the effect of activating JNK signaling in AgRP neurons on energy homeostasis, we monitored the body weight of male control and AgRP JNK1CA mice. Whereas body weight did not differ between genotypes at the beginning of our analysis, AgRP JNK1CA mice displayed progressively increased body weight starting at the age of 5 weeks, which continued until the end of our study at 28 weeks of age ( Figure 3A) . Moreover, analysis of body composition revealed increased adipose tissue mass in AgRP JNK1CA compared to control mice ( Figure 3B ), which was associated with adipocyte hyperplasia ( Figures 3C and 3D ). In light of the increased body weight and adiposity of AgRP JNK1CA mice, we aimed to identify the mechanism of how AgRP-neuron-specific activation of JNK signaling caused a positive energy balance. These analyses revealed that daily food intake was significantly increased upon activation of JNK signaling in AgRP cells ( Figure 3E ), whereas locomotor activity and energy expenditure remained unaltered in AgRP JNK1CA mice compared to control mice ( Figures 3F and 3G ). Thus, activation of JNK signaling in AgRP neurons is sufficient to promote hyperphagia and obesity development in mice.
Unaltered Glucose Homeostasis in AgRP
JNK1CA Mice Insulin action in AgRP neurons is critical for the control of hepatic glucose output (Kö nner et al., 2007; Lin et al., 2010) . Insulin activates the phosphatidylinositol 3-kinase (PI3K) cascade in AgRP (D) Fat cell area distribution of control (n = 3) and AgRP JNK1CA mice (n = 4) at the age of 25 weeks.
(E) Average ad libitum food intake at the age of 6 weeks of control (n = 12) and AgRP JNK1CA mice (n = 12).
(F) Locomotor activity at the age of 6 weeks of control (n = 7) and AgRP JNK1CA mice (n = 7).
(G) Energy expenditure at the age of 6 weeks of control (n = 7) and AgRP JNK1CA mice (n = 7). Figure S3 ). Thus, these experiments revealed the development of leptin, but not insulin resistance, as a consequence of JNK activation in AgRP neurons.
Activation of IKK2 Signaling Increases the Firing Rate of AgRP Neurons
Because activation of JNK signaling in AgRP neurons was sufficient to induce obesity and leptin resistance, but neither caused neuronal insulin resistance nor impaired systemic glucose metabolism, we sought to investigate whether chronic activation of IKK2 signaling in AgRP neurons would impact on the regulation of energy homeostasis and/or glucose homeostasis. Therefore, we generated mice expressing a constitutive active IKK2 mutant (IKK2CA) (Sasaki et al., 2006) (E) Blood glucose levels during glucose tolerance test of control (n = 9) and AgRP JNK1CA (n = 11) mice.
The mice were fasted for 6 hr before the injection with 20% glucose (10 ml/kg). 5B ). Constitutive IKK2 activation in AgRP neurons did not affect the total number of LacZ + -AgRP cells ( Figure 5C ). Collectively, these experiments reveal successful activation of IKK2 signaling in AgRP neurons in mice, already in those that express only one copy of the IKK2CA allele.
Next Figures 4D-4F ). Again, other basic electrophysiological properties remained unaltered (Figure S1 ). These experiments indicate that activation of both major inflammatory mediators JNK1 and IKK2 propagate increased activity of orexigenic AgRP/NPY neurons in the arcuate nucleus in a cell-autonomous manner. Figures 6C and 6D ) despite a slightly elevated food intake compared to controls ( Figure 6E ). Similarly, locomotor activity and energy expenditure remained unaltered between genotypes ( Figures 6F and 6G ). Figures 7C  and 7D ). Of note, at basal levels, the amount of PIP3 formation was also indistinguishable between AgRP IKK2CA;LacZ and control mice ( Figure 7E ). Thus, activating IKK2 signaling in AgRP neurons causes cell-autonomous insulin resistance and subsequently impairs systemic insulin sensitivity in the absence of altered body weight regulation.
Activation of IKK2 Signaling in AgRP Neurons
DISCUSSION
Hypothalamic inflammation is recognized as a critical feature of diet-induced neuronal leptin and insulin resistance (Zhang et al., 2008; Thaler et al., 2012) . Whereas hypothalamic activation of inflammatory pathways including that of JNK-and IKK2-mediated signaling had been reported early upon high-fat feeding of mice ( De Souza et al., 2005) , the functional significance of this phenomenon remained unclear, because it was conceivable that hypothalamic inflammation could contribute to the development of CNS insulin and/or leptin resistance or maybe even represent a homeostatic, compensatory mechanism to counteract the consequences of obesity. Nevertheless, recent experiments demonstrating that attenuation of neuronal IKK2, JNK1, TLR, and ER stress signaling protect from the development of diet-induced obesity (Zhang et al., 2008; Kleinridders et al., 2009; indicate that hypothalamic inflammation at least chronically contributes to the manifestation of the metabolic syndrome.
However, the contribution of different cell types that reside in the hypothalamus, such as astrocytes, microglia, stem cells, endothelial cells, and neurons, to the initiation and manifestation of hypothalamic inflammation is only partially understood (García-Cá ceres et al., 2013; Gao et al., 2014; Purkayastha and Cai, 2013; Gosselin and Rivest, 2008) . Moreover, due to the diversity and partial functional antagonism of distinct hypothalamic neurons, we sought to first clarify the role of inflammatory signaling in AgRP neurons of the arcuate nucleus in the manifestation of the metabolic syndrome. To this end, the present study clearly reveals that activation of JNK and IKK2 in these cells is sufficient to initiate key features of the metabolic syndrome, even in the absence of additional environmental triggers, such as high-fat feeding. At the same time, our results demonstrate that activation of inflammatory signaling pathways in neurons is a crucial determinant in the pathogenesis of obesity and impaired insulin sensitivity, even in the absence of altered microglia function.
Interestingly, our experiments reveal common and distinct consequences of AgRP-neuron-restricted JNK versus IKK2 activation. Activation of either inflammatory signaling branch results in increased firing of AgRP neurons. In fact, both JNK and IKK2 have been demonstrated to regulate glutamatergic signaling and synapse maturation, raising the possibility that both inflammatory kinases promote AgRP neuron excitability via similar or distinct pathways (Thomas et al., 2008; Bockhart et al., 2009; Ahn and Choe, 2010; Schmeisser et al., 2012) . Interestingly, despite the fact that, in both models, AgRP firing is increased by $2-fold ( Figure S1I ), only the AgRP JNK1CA mice develop obesity. As optogenetic stimulation has clearly defined that robustly increasing AgRP neuron firing evokes voracious feeding, our experiments reveal that slight increases in AgRP firing per se do not cause obesity. Despite increased firing at young age, as detected in our animals, compensatory mechanisms might normalize electrical activity of these cells in long term despite increased JNK and IKK2 activity. Ultimately, we cannot rule out that yet unidentified cellular heterogeneity of AgRP neurons-as observed for POMC neuronsmay contribute to these differential outcomes . Despite the similar alterations of neuronal firing upon JNK and IKK2 activation, only activating JNK in AgRP neurons promotes initially cellular and subsequently systemic leptin resistance. These findings are consistent with reports that mice with targeted disruption of leptin receptor signaling in the AgRP neurons develop hyperphagia and obesity (van de Wall et al., 2008) . Moreover, AgRP neurons have been reported to be one of the first hypothalamic neuronal populations to sense changes in plasma metabolic signals and develop cellular leptin resistance (Olofsson et al., 2013) , possibly as a consequence of activating inflammatory signaling cascades, i.e., JNK. Indeed, it has been demonstrated that JNK activation can promote SOCS-3 expression, a well-characterized inhibitor of leptin action (Qin et al., 2007; Bjørbaek et al., 1999; Howard et al., 2004) . On the other hand, JNK activation in AgRP neurons fails to promote cellautonomous and systemic insulin resistance, despite the fact that JNK-dependent serine phosphorylation of IRS-1 has been proposed to cause insulin resistance, at least in vitro (Aguirre et al., 2002) . However, mice with a mutation of IRS-1 serine 307 to alanine, which prevents this phosphorylation, are surprisingly more insulin resistant under high-fat diet conditions than their control littermates (Copps et al., 2010) . These results indicate that JNK activation does not necessarily result in attenua- On the other hand, activation of IKK2 in AgRP neurons causes cell-autonomous and systemic insulin resistance in the absence of leptin resistance and obesity. In fact, this observation is consistent with the notion that disruption of insulin signaling in the AgRP neurons impairs systemic insulin sensitivity through impairing insulin's ability to suppress hepatic glucose production but without affecting body weight regulation (Kö nner et al., 2007) . In contrast, previous studies had shown that ablation of IKK2 from the CNS was sufficient to largely reduce the development of obesity and leptin resistance upon high-fat diet feeding (Zhang et al., 2008) . This points to the possibility that IKK2 acts in other neurons to promote weight gain and leptin resistance, potentially through its action on hypothalamic neurogenesis (Li et al., 2012) .
In summary, our results indicate that both JNK1 and IKK2 inflammatory pathways are sufficient to impair aspects of energy and glucose metabolism when activated in AgRP neurons, clearly assigning a functional role of these signaling pathways in this cell type to the manifestation of the metabolic syndrome.
EXPERIMENTAL PROCEDURES Animal Care
All animal procedures were conducted in compliance with protocols approved by local government authorities (Bezirksregierung Kö ln) and were in accordance with NIH guidelines. Mice were housed in groups of 3-5 at
22
C-24 C using a 12 hr light/12 hr dark cycle. Animals were fed normal chow diet (Teklad Global Rodent 2018; Harlan) containing 53.5% carbohydrates, 18.5% protein, and 5.5% fat (12% of calories from fat) or high-fat diet (only for the experiment of Figure 1A ; HFD; C1057; Altromin) containing 32.7% carbohydrates, 20% protein, and 35.5% fat (55.2% of calories from fat). Animals had ad libitum access to water at all times, and food was only withdrawn if required for an experiment. Body weight was measured once a week.
Generation of Mice
Only male mice were used in these studies to avoid the effect of different stages of estrous cycle on glucose homeostasis. NPY GFP , R26Stop FL JNK1CA, R26Stop FL IKK2CA, Z/EG, LacZ, and AgRP Cre mice have been described previously (Pal et al., 2013; Sasaki et al., 2006; Novak et al., 2000; Tong et al., 2008) . All mouse strains had been crossed onto a C57B6/N background for at least three generations, and littermate controls were used at all times except in reporter animal breedings for the AgRP. Instead, we crossed AgRP 
Analytical Procedures
Blood glucose values were determined from whole venous blood using an automatic glucose monitor (Contour; Bayer). Serum hormones were measured as recently described using commercially available ELISAs .
Indirect Calorimetry, Physical Activity, and Food Intake All measurements were performed in a PhenoMaster System (TSE systems), which allows measurement of metabolic performance and activity monitoring by an infrared light-beam frame. Mice were placed at room temperature (22 C-24 C) in 7.1 l chambers of the PhenoMaster open circuit calorimetry.
Mice were allowed to acclimatize in the chambers for at least 24 hr. Food and water were provided ad libitum in the appropriate devices and measured by the built-in automated instruments. Locomotor activity and parameters of indirect calorimetry were measured for at least the following 48 hr. Presented data are average values obtained in these recordings.
Body Composition
Nuclear magnetic resonance was employed to determine body composition using the NMR Analyzer minispeq mq7.5 (Bruker Optik).
Perforated Patch Recordings
AgRP neurons were recorded at room temperature under current and voltage clamp in the perforated patch configuration using an EPC10 patch-clamp amplifier (HEKA). For detailed information, see the Supplemental Experimental Procedures.
Data Analysis and Statistical Methods
Data analysis was performed with Igor Pro 6 (Wavemetrics) and Graphpad Prism (version 5.0b; Graphpad Software). Numerical values are given as mean ± SE. Box plots are generated according to Tukey; means are reflected by ''+'' and medians by the dash, respectively. To determine differences in means, t tests were performed. A significance level of 0.05 was accepted for all tests. *p % 0.05; **p % 0.01; ***p % 0.001 versus controls.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and three figures and can be found with this article online at http://dx.doi. org/10.1016/j.celrep.2014.10.045.
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Supplemental Experimental Procedures
Immunohistochemistry GFP/phospho-c-Jun and PIP3/LacZ double stainings were performed similarly to previously reported protocols (Belgardt et al., 2008; Plum et al., 2006) . The following antibodies were used, "-GFP antibody (Abcam, #13970, dilution 1: 1000), "-p-c-jun antibody (Cell Signaling, #3270, dilution 1: 800), "-pSTAT3 antibody (Cell Signaling, #9145, dilution 1:100), "-pI#B" antibody (Cell Signaling, #2589, dilution 1:100). After overnight incubation at 4°C, we used goat "-chicken (Jackson, #103-095-155, FITC-coupled, dilution 1:500) and goat "-rabbit (Molecular Probes, #A11012, Alexa 594-coupled, dilution 1:500). Images were captured using a Leica S5
confocal microscope and analyzed, as described below, using ImageJ software (NIH).
In the Figures 1B, 1D, 2B, 2C , 5B, cells with immunoreactivity above threshold were counted manually as positive and marked digitally to prevent multiple counts, for each cell immunoreactivity was assessed in every channel (at least 2 sections/animal were used for quantification).
Co-staining for both pSTAT3 and LacZ immunoreactivity was quantified in 10 confocal slices, at 1µm intervals per animal from three animals per group (at least 2 hemisections/animal). In detail, maximum intensity projections were prepared for each series of confocal images, separately for pSTAT3 and LacZ immunoreactivity.
Each image was binarized to isolate immunoreactive positive cells from the background and compensate for differences in fluorescence intensity. To determine co-localization, the integrated density of overlapping pixels was measured from the pSTAT3 and LacZ binarized images. The integrated density, depicted in Figure 2B , is therefore proportional to the intensity of pSTAT3 and LacZ immunoreactivity colocalization. To quantify the intensity of pSTAT3 immunoreactivity in non-LacZ cells (LacZ -), the same binarized images of pSTAT3 and LacZ immunoreactivity were used for analysis as for Figure S2A . Specifically, the binarized image of LacZ was subtracted from the binarized image of pSTAT3 to define the pSTAT3 immunoreactivity in LacZ -cells (non-AgRP neurons), and the integrated density of the resulting image defined the intensity depicted in Figure S2B .
For semi-quantitative analysis of PIP3 levels in AgRP neurons, $-galactosidase positive neurons were assessed in ARC slices of control AgRP LacZ and AgRP JNK1CA;LacZ mice, which had been injected either with saline or insulin as previously described (Plum et al., 2006b) . In detail, the amount of PIP3 was classified as low (immunoreactive cytoplasmic dots/sprinkles in the proximity of the nucleus at background levels, i.e. 6 or fewer dots, no cloudy aspect, no confluent areas), moderate (dots/sprinkles at levels above background, i.e. more than 6 dots, cloudy aspect), or high (more than 20 dots/sprinkles, cloudy with confluent areas).
Animals and brain slice preparation
Electrophysiological experiments were performed on brain slices from 35-to 42-day male mice. The animals were anesthetized with halothane (B4388; Sigma-Aldrich, Taufkirchen, Germany) and subsequently decapitated. The brain was rapidly removed and a block of tissue containing the ARC was immediately cut out. Coronal slices (260 !M) containing the ARC were cut with a vibration microtome (HM-650 V;
Thermo Scientific, Walldorf, Germany) under cold (4 °C), carbonated (95% O 2 and 5% CO 2 ), glycerol-based modified artificial cerebrospinal fluid (GaCSF) to enhance the viability of neurons. GaCSF contained (in mM): 250 Glycerol, 2.5 KCl, 2 MgCl 2 , 2 CaCl 2 , 1.2 NaH 2 PO 4 , 10 HEPES, 21 NaHCO 3 , 5 Glucose adjusted to pH 7.2 with NaOH resulting in an osmolarity of ~310 mOsm. Brain slices were transferred into carbogenated artificial cerebrospinal fluid (aCSF). First, they were kept for 20 min in a 35 °C 'recovery bath' and then stored at room temperature (24 °C) for at least 30 min prior to recording. aCSF contained (in mM): 125 NaCl, 2.5 KCl, 2 MgCl 2 , 2 CaCl 2 , 1.2 NaH 2 PO 4 , 21 NaHCO 3 , 10 HEPES, and 5 Glucose adjusted to pH 7.2 with NaOH resulting in an osmolarity of ~310 mOsm.
Perforated patch recordings
Slices were transferred to a recording chamber (~3 ml volume) and continuously superfused with carbogenated aCSF at a flow rate of ~2 ml·min [Wavemetrics, Lake Oswego, OR, USA]).
Perforated patch recordings were performed using protocols modified from Horn and
Marty (Horn and Marty, 1988) and Akaike and Harata (Akaike and Harata, 1994) .
Electrodes with tip resistances between 3 and 5 M& were fashioned from borosilicate glass (0.86 mm inner diameter; 1.5 mm outer diameter; GB150-8P; Science Products, Hofheim, Germany) with a vertical pipette puller (PP-830; Narishige, London, UK).
Perforated patch recordings were performed with ATP and GTP free pipette solution containing (in mM): 128 K-gluconate, 10 KCl, 10 HEPES, 0.1 EGTA, 2 MgCl 2 adjusted to pH 7.3 with KOH resulting in an osmolarity of ~300 mOsm. ATP and GTP were omitted from the intracellular solution to prevent uncontrolled permeabilization of the cell membrane (Lindau and Fernandez, 1986) . The patch pipette was tip filled with internal solution and back filled with tetraethylrhodaminedextran (D3308, Invitrogen, Eugene, OR, USA) and amphotericin B containing internal solution (100-250 !g·ml -1 ; A4888; Sigma) to achieve perforated patch recordings. Amphotericin B was dissolved in dimethyl sulfoxide (final concentration:
0.2 -0.5%; DMSO; D8418, Sigma) as described in (Rae et al., 1991) and was added to the modified pipette solution shortly before use. The used DMSO concentration had no obvious effect on the investigated neurons. Experiments were carried out at ~32°C using an inline solution heater (SH27B; Warner Instruments, Hamden, CT, USA) operated by a temperature controller (TC-324B; Warner Instruments). During the perforation process access resistance (R a ) was constantly monitored and experiments were started after R a and the action potential (AP) amplitude were stable (~10-30 min). A change to the whole-cell configuration was indicated by diffusion of tetraethylrhodamine-dextran into the neuron. Such experiments were rejected. For each neuron, the firing rate and the membrane potential was determined by averaging periods of 5 minutes using Spike2.
